Skip to main content
Lensar Logoopens in a new window
  • TECHNOLOGY
    • LENSAR Laser System
    • ALLY Adaptive Cataract Treatment System
  • ABOUT US
  • INVESTORS
  • CONTACT US
  • SUPPORT
    • Marketing Portal
    • Clinical Training
    • Certificates and Supplies
    • Electronic User Manuals
LENSAR Corporate Site
  • HOME
  • TECHNOLOGY
  • ABOUT US
  • INVESTORS
  • CONTACT US
  • SUPPORT

Executive Management

Investors Menu
  • Overview
    • News
    • Events & Presentations
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Analyst Coverage
    • Financials
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
      • Board of Directors
      • Committee Composition
      • Whistleblower
    • Resources
      • Investor Email Alerts
      • Investor Contacts

Executive Management Carousel

Nicholas Curtis, Chief Executive Officer

Nicholas T. Curtis has served as our Chief Executive Officer and as a member of our board of directors since February 2012. Prior to this, Mr. Curtis served as our chief commercial officer from August 2010 until February 2012. Before joining us, Mr. Curtis was the vice president of sales and chief commercial officer of WaveTec Vision Systems, Inc., a privately held ophthalmic medical device company. Mr. Curtis served as a senior vice president of sales and marketing at STAAR Surgical Company, a publicly held company specializing in the manufacturing and marketing of ophthalmic surgery devices, from August 2002 until August 2008. Mr. Curtis has a B.S. from Northwestern University.

Alan Connaughton, Chief Operating Officer

Alan B. Connaughton has served as our chief operating officer since April 2015. Prior to this, Mr. Connaughton was our vice president of operations from January 2008 until April 2015. Mr. Connaughton has over 20 years of experience working with medical device companies. Mr. Connaughton received a B.S. from University College Galway, an M.S. from Queens University College and an M.B.A. from Rollins College.

Thomas Staab, II, Chief Financial Officer

Thomas R. Staab, II has served as our Chief Financial Officer since May 2020. Before joining us, Mr. Staab served as a Senior Vice President, Chief Financial Officer and Treasurer at BioCryst Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company, from July 2011 to February 2020. Prior to BioCryst, Mr. Staab served as Executive Vice President, Chief Financial Officer and Treasurer of Inspire Pharmaceuticals from May 2003 through its acquisition by Merck & Co., Inc. in May 2011, and acting Chief Financial Officer and Treasurer at Triangle Pharmaceuticals, Inc. through its acquisition by Gilead Sciences, Inc. in 2003. Before joining the biopharmaceutical industry, Mr. Staab spent eight years working for PricewaterhouseCoopers LLP providing audit and business advisory services to national and multi-national corporations in various industries. He is a Certified Public Accountant and received a B.S. in Business Administration and a Master of Accounting from the University of North Carolina at Chapel Hill.

Quick Links

  • SEC Filings

IR Contact

For IR Questions

888.536.7271
Send Email

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At LENSAR, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to LENSAR to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

REQUEST A MEETING WITH MANAGEMENT
LENSAR logo

© 2023 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, the LENSAR Cataract Laser with Augmented Reality logo, Streamline, IntelliAxis, IntelliAxis Refractive Capsulorhexis, ALLY Adaptive Cataract Treatment System, and the ALLY Adaptive Cataract Treatment System logo are registered trademarks and Intelligent Incisions, Augmented Reality, and Adaptive Intelligence are trademarks of LENSAR, Inc. All other trademarks are the property of their respective owners.

50-00159-000 Rev. C 01/23

USEFUL LINKS

Careers
Privacy Policy
Terms of Use
Business Ethics





Powered By Q4 Inc. 5.86.0.1 (opens in new window)